This webinar provides the latest focused ultrasound updates highlighting NaviFUS, a company based in Taiwan that is dedicated to helping patients with neurological diseases, like glioblastoma (GBM) and epilepsy, by providing novel focused ultrasound platform solutions to open the blood-brain barrier and enhance drug delivery and neuromodulation.
Presenters include Dr. Arthur Lung, CEO of NaviFUS, along with two leading clinicians, Dr. Kuo-Chen Wei and Dr. Hsiang-Yu Yu, to discuss their groundbreaking clinical projects using NaviFUS devices.
Dr. Wei, from Chang Gung Memorial Hospital Linkou Medical Center Department of Neurosurgery, is exploring the use of focused ultrasound for glioblastoma multiforme (GBM), a particularly aggressive form of brain cancer. His work shows promise in using NaviFUS devices to non-invasively deliver drugs directly to the tumor site, potentially improving treatment outcomes for GBM patients.
Dr. Yu, from the Division of Epilepsy at Taipei Veterans General Hospital, is investigating the use of focused ultrasound for epilepsy. By targeting specific areas of the brain, Dr. Yu's work with NaviFUS devices could provide a non-invasive alternative to traditional surgery for some epilepsy patients, reducing the risk of complications and improving quality of life.
For more information visit:
[ Ссылка ]
[ Ссылка ]
#FocusedUltrasound #NaviFUS #MedicalInnovation #GBM #EpilepsyTreatment #ClinicalResearch #CuringWithSound
